# Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.

> PubMed lists PMID 41950644 in Biomaterials as Journal Article, with publication-date metadata of 2026-04-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41950644-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-14
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41950644-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41950644-teriparatide-v1.json
- Content SHA-256: `cbc92527f6f4a36606222d93a94435334dabc95ed10bc7e7fc0ec339c34a42a8`

## Claims and source pins

### Headline

Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment. ([`pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f`](#source-pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f))

### Summary

PubMed lists PMID 41950644 in Biomaterials as Journal Article, with publication-date metadata of 2026-04-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f`](#source-pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f))

### Paragraph 1

PubMed lists PMID 41950644 in Biomaterials as Journal Article, with publication-date metadata of 2026-04-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f`](#source-pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f`](#source-pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f))

## Sources

<a id="source-pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f"></a>
- **Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment. · retained source version 1:2026-07-14:current:138dc8b36d3f34b7269528edda14cf873c453bd97108618ae60e24966dcbc49c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41950644/) (`pubmed-observation-pmid-41950644-2026-07-14-138dc8b36d3f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41950644-teriparatide-v1.json SHA-256: cbc92527f6f4a36606222d93a94435334dabc95ed10bc7e7fc0ec339c34a42a8.